The weekly litigation news digest is live. Subscribe now

IP Verse

Schering competitive analysis

Loading summary...

Latest patents of Schering opposed by its competitors

Explore Schering's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 20, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2399588
Apr 29, 2020Nucleoside Derivatives As Inhibitors Of Rna-Dependent Rna Viral Polymerase1
EP1747001
Oct 10, 2018Management Of Breakthrough Bleeding In Extended Hormonal Contraceptive Regimens2
EP2475388
Nov 8, 2017Use Of Il-33 Antagonists To Treat Fibrotic Disease1

Latest PTAB cases involving Schering

Discover the latest PTAB cases involving Schering, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Schering with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 20, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SCHERING - 4 - -
ELI LILLY4251715
GILEAD SCIENCES53186